Literature DB >> 17085944

Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin.

Nancy Unanue1, Rodrigo Bazaes, Germán Iñiguez, Fanny Cortés, Alejandra Avila, Verónica Mericq.   

Abstract

Prader-Willi syndrome (PWS) is a genetic disorder characterized by dysmorphic features, obesity, hypogonadism, hypotonia and mental retardation. Obesity has been linked to insulin resistance and the latter has also been associated with premature adrenarche. Since up to date a controlled study to investigate adrenarche and its hormonal regulation was lacking in PWS, our aim was to assess whether prepubertal PWS patients develop premature adrenarche and its relationship with markers of insulin sensitivity. Fourteen prepubertal children with PWS (6 M, 8 F) and 10 non-syndromal simple obese matched controls (5 M, 5 F) participated (mean age: 7.62 +/- 1.84 years). A fasting blood sample was obtained for adrenal and ovarian androgens, sex hormone binding globulin, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1, leptin, adiponectin and a lipid profile. Thereafter an oral glucose tolerance test was performed. PWS patients were smaller at birth and a higher proportion displayed premature pubarche. No differences were found in testosterone, androstenedione, sex hormone binding globulin, free androgen index, homeostatic model assessment-IR, 2-hour insulin, leptin or adiponectin levels. 17-hydroxyprogesterone and DHEAS levels however, were significantly higher in PWS. IGF-I levels were significantly lower in PWS and correlated significantly with height SDS (p < 0.05). In conclusion, a higher proportion of premature adrenarche in our PW patients was observed, which was not explained by differences in insulin sensitivity or plasma levels of adipokines and IGF-I.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085944     DOI: 10.1159/000096742

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  8 in total

Review 1.  The evolutionary biology of child health.

Authors:  Bernard Crespi
Journal:  Proc Biol Sci       Date:  2011-02-02       Impact factor: 5.349

2.  Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.

Authors:  Dong-Kyu Jin
Journal:  Korean J Pediatr       Date:  2012-07-17

Review 3.  Colloquium papers: Transfers and transitions: parent-offspring conflict, genomic imprinting, and the evolution of human life history.

Authors:  David Haig
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

4.  Systematic review of the clinical and genetic aspects of Prader-Willi syndrome.

Authors:  Dong Kyu Jin
Journal:  Korean J Pediatr       Date:  2011-02-28

5.  Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.

Authors:  Andrea M Haqq; Michael Muehlbauer; Laura P Svetkey; Christopher B Newgard; Jonathan Q Purnell; Steven C Grambow; Michael S Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2007-07-30       Impact factor: 3.478

Review 6.  Adipokines: A gear shift in puberty.

Authors:  Desirée Nieuwenhuis; Natàlia Pujol-Gualdo; Ilse A C Arnoldussen; Amanda J Kiliaan
Journal:  Obes Rev       Date:  2020-01-30       Impact factor: 9.213

Review 7.  Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.

Authors:  Luigi Napolitano; Biagio Barone; Simone Morra; Giuseppe Celentano; Roberto La Rocca; Marco Capece; Vincenzo Morgera; Carmine Turco; Vincenzo Francesco Caputo; Gianluca Spena; Lorenzo Romano; Luigi De Luca; Gianluigi Califano; Claudia Collà Ruvolo; Francesco Mangiapia; Vincenzo Mirone; Nicola Longo; Massimiliano Creta
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

8.  Influence of molecular classes and growth hormone treatment on growth and dysmorphology in Prader-Willi syndrome: A multicenter study.

Authors:  Ranim Mahmoud; Anna Leonenko; Merlin G Butler; Pamela Flodman; June-Anne Gold; Jennifer L Miller; Elizabeth Roof; Elisabeth Dykens; Daniel J Driscoll; Virginia Kimonis
Journal:  Clin Genet       Date:  2021-03-13       Impact factor: 4.296

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.